BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30775645)

  • 1. Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure.
    Dohle W; Prota AE; Menchon G; Hamel E; Steinmetz MO; Potter BVL
    ACS Omega; 2019 Jan; 4(1):755-764. PubMed ID: 30775645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure.
    Dohle W; Jourdan FL; Menchon G; Prota AE; Foster PA; Mannion P; Hamel E; Thomas MP; Kasprzyk PG; Ferrandis E; Steinmetz MO; Leese MP; Potter BVL
    J Med Chem; 2018 Feb; 61(3):1031-1044. PubMed ID: 29227648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antitubulin, and antiproliferative SAR of C3/C1-substituted tetrahydroisoquinolines.
    Dohle W; Leese MP; Jourdan FL; Major MR; Bai R; Hamel E; Ferrandis E; Kasprzyk PG; Fiore A; Newman SP; Purohit A; Potter BV
    ChemMedChem; 2014 Feb; 9(2):350-70. PubMed ID: 24436228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Difluoromethoxy-Substituted Estratriene Sulfamates: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Steroid Sulfatase Inhibition.
    Dohle W; Asiki H; Gruchot W; Foster PA; Sahota HK; Bai R; Christensen KE; Hamel E; Potter BVL
    ChemMedChem; 2022 Dec; 17(23):e202200408. PubMed ID: 36109340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptors.
    Dohle W; Leese MP; Jourdan FL; Chapman CJ; Hamel E; Ferrandis E; Potter BV
    ChemMedChem; 2014 Aug; 9(8):1783-93. PubMed ID: 24819406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
    Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
    Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, anti-tubulin and antiproliferative SAR of steroidomimetic dihydroisoquinolinones.
    Leese MP; Jourdan FL; Major MR; Dohle W; Thomas MP; Hamel E; Ferrandis E; Mahon MF; Newman SP; Purohit A; Potter BV
    ChemMedChem; 2014 Apr; 9(4):798-812. PubMed ID: 24596315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydroisoquinolinone-based steroidomimetic and chimeric microtubule disruptors.
    Leese MP; Jourdan FL; Major MR; Dohle W; Hamel E; Ferrandis E; Fiore A; Kasprzyk PG; Potter BV
    ChemMedChem; 2014 Jan; 9(1):85-108, 1. PubMed ID: 24124095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate.
    Jourdan F; Leese MP; Dohle W; Hamel E; Ferrandis E; Newman SP; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2010 Apr; 53(7):2942-51. PubMed ID: 20225862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.
    Huang L; Huang J; Nie H; Li Y; Song L; Wu F
    RSC Med Chem; 2021 Aug; 12(8):1374-1380. PubMed ID: 34458740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of 3-substituted analogues of 1,2,3,4-tetrahydroisoquinoline as inhibitors of phenylethanolamine N-methyltransferase.
    Grunewald GL; Sall DJ; Monn JA
    J Med Chem; 1988 Apr; 31(4):824-30. PubMed ID: 3351861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.
    Lin CM; Singh SB; Chu PS; Dempcy RO; Schmidt JM; Pettit GR; Hamel E
    Mol Pharmacol; 1988 Aug; 34(2):200-8. PubMed ID: 3412321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morpholino derivatives of benzyl-benzodioxole, a study of structural requirements for drug interactions at the colchicine/podophyllotoxin binding site of tubulin.
    Batra JK; Jurd L; Hamel E
    Biochem Pharmacol; 1986 Nov; 35(22):4013-8. PubMed ID: 3778522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
    Sharma S; Gupta MK; Saxena AK; Bedi PM
    Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization.
    Gastpar R; Goldbrunner M; Marko D; von Angerer E
    J Med Chem; 1998 Dec; 41(25):4965-72. PubMed ID: 9836614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents.
    Romagnoli R; Baraldi PG; Prencipe F; Oliva P; Baraldi S; Salvador MK; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Ronca R; Bortolozzi R; Mariotto E; Porcù E; Basso G; Viola G
    Sci Rep; 2017 Apr; 7():46356. PubMed ID: 28406191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor agents. 174. 2',3',4',5,6,7-Substituted 2-phenyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.
    Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
    J Med Chem; 1997 Jul; 40(14):2266-75. PubMed ID: 9216846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
    Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
    Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agents.
    Zaraei SO; Dohle W; Anbar HS; El-Gamal R; Leblond B; Foster PA; Al-Tel TH; Potter BVL; El-Gamal MI
    Bioorg Med Chem; 2024 Mar; 101():117645. PubMed ID: 38401456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.